Charles Schwab’s Telomir Pharmaceuticals TELO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-46,406	Closed	-$150K	–	3599
2025 Q1	$150K	Hold	46,406	–	–	﹤0.01%	3292
2024 Q4	$191K	Buy	46,406 +35,556	+328%	+$146K	﹤0.01%	3336
2024 Q3	$69.7K	Hold	10,850	–	–	﹤0.01%	3394
2024 Q2	$52.2K	Buy	+10,850	New	+$52.2K	﹤0.01%	3510